• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4597353)   Today's Articles (157)   Subscriber (49354)
Number Citation Analysis
26
de Gooijer MC, Guillén Navarro M, Bernards R, Wurdinger T, van Tellingen O. An Experimenter's Guide to Glioblastoma Invasion Pathways. Trends Mol Med 2018;24:763-780. [PMID: 30072121 DOI: 10.1016/j.molmed.2018.07.003] [Citation(s) in RCA: 73] [Impact Index Per Article: 12.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2018] [Revised: 07/03/2018] [Accepted: 07/06/2018] [Indexed: 12/25/2022]
27
O'connor DP, Walsh L, Fan Y, Tarrant F, Chin SF, Schouten P, Caldas C, Bernards R, Chonghaile TN, Gallagher W. Abstract 5791: Bromodomain inhibitors for the treatment of invasive lobular carcinoma. Cancer Res 2018. [DOI: 10.1158/1538-7445.am2018-5791] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
28
Mainardi S, Mulero-Sánchez A, Prahallad A, Germano G, Bosma A, Lieftink C, Nadal E, Bardelli A, Villanueva A, Bernards R. PO-019 PTPN11 is a therapeutic target in KRAS mutant lung cancer. ESMO Open 2018. [DOI: 10.1136/esmoopen-2018-eacr25.554] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]  Open
29
Dwane L, Das S, Moran B, O’Connor A, Mulrane L, Jirstrom K, Bernards R, Gallagher W, Ní Chonghaile T, O’Connor D. PO-345 The role of the deubiquitinase USP11 in endocrine-driven breast cancer. ESMO Open 2018. [DOI: 10.1136/esmoopen-2018-eacr25.375] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]  Open
30
Pogacar Z, Brunen D, Zaretsky J, Hu-Leiskovan S, Bernards R. PO-404 Using functional genetic screens to understand cancer immune evasion. ESMO Open 2018. [DOI: 10.1136/esmoopen-2018-eacr25.915] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]  Open
31
Neto J, Van Tellingen O, Villanueva A, Bernards R. 16 Quadruple vertical targeting of an oncogenic pathway as a treatment strategy to prevent drug resistance. ESMO Open 2018. [DOI: 10.1136/esmoopen-2018-eacr25.16] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]  Open
32
Whitworth PW, Baron P, Beitsch PD, Yoder E, Treece T, Audeh MW, Dinjens WN, Bernards R, Groenendijk F. Expression of estrogen receptor variants in ER+ basal-type breast cancers that respond to therapy like ER- breast cancers. J Clin Oncol 2018. [DOI: 10.1200/jco.2018.36.15_suppl.e24289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
33
Robinson PA, Treece T, Osipo C, Qamar R, Zon R, Levine EG, Budway R, Mavromatis BH, Untch S, Bernards R, Audeh MW, Soliman HH. Effect of metabolic syndrome on risk of recurrence and immune pathways in invasive lobular carcinoma disparately compared to ductal. J Clin Oncol 2018. [DOI: 10.1200/jco.2018.36.15_suppl.e24229] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
34
Wang L, Leite de Oliveira R, Huijberts S, Bosdriesz E, Pencheva N, Brunen D, Bosma A, Song JY, Zevenhoven J, Los-de Vries GT, Horlings H, Nuijen B, Beijnen JH, Schellens JH, Bernards R. An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential. Cell 2018;173:1413-1425.e14. [DOI: 10.1016/j.cell.2018.04.012] [Citation(s) in RCA: 182] [Impact Index Per Article: 30.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2017] [Revised: 02/14/2018] [Accepted: 04/11/2018] [Indexed: 12/15/2022]
35
Leite de Oliveira R, Bernards R. Anti-cancer therapy: senescence is the new black. EMBO J 2018;37:embj.201899386. [PMID: 29669859 DOI: 10.15252/embj.201899386] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]  Open
36
Dwane L, Das S, Moran B, O'Connor AE, Mulrane L, Dirac AM, Jirstrom K, Crown JP, Bernards R, Gallagher WM, Ní Chonghaile T, O'Connor DP. Abstract P2-05-02: Functional genomic screening identifies ubiquitin-specific protease 11 (USP11) as a novel regulator of ER-alpha transcription in breast cancer. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p2-05-02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
37
Walsh L, Fan Y, Tarrant F, Chin SF, Schouten P, Caldas C, Bernards R, Ni Chonghaile T, Gallagher WM. Abstract P1-09-02: Bromodomain inhibitors for the treatment of invasive lobular carcinoma. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p1-09-02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
38
Leite de Oliveira R, Wang L, Bernards R. With great power comes great vulnerability. Mol Cell Oncol 2018;5:e1509488. [PMID: 30525088 PMCID: PMC6276853 DOI: 10.1080/23723556.2018.1509488] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2018] [Revised: 07/27/2018] [Accepted: 07/28/2018] [Indexed: 04/19/2023]
39
Clarke CN, Lee MS, Wei W, Manyam G, Jiang ZQ, Lu Y, Morris J, Broom B, Menter D, Vilar-Sanchez E, Raghav K, Eng C, Chang GJ, Simon I, Bernards R, Overman M, Mills GB, Maru D, Kopetz S. Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival. Ann Surg Oncol 2017;24:4051-4058. [PMID: 28936799 PMCID: PMC6063735 DOI: 10.1245/s10434-017-6054-5] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2017] [Indexed: 01/07/2023]
40
Caumanns J, Wisman G, Berns K, Tomar T, Fehrmann R, Bernards R, Zee AVD, Jong SD. Abstract 1219: Integrative kinome exome sequencing and copy number profiling of ovarian clear cell carcinoma. Cancer Res 2017. [DOI: 10.1158/1538-7445.am2017-1219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
41
Walsh L, Moran B, Das S, Tarrant F, Schouten P, Chin SF, Bernards R, Caldas C, Gallagher W, Chonghaile* TN, O'Connor* D. Abstract 4674: Epigenetic modulators for the treatment of invasive lobular carcinoma breast cancer. Cancer Res 2017. [DOI: 10.1158/1538-7445.am2017-4674] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
42
Wang VE, Doench J, Root D, Bernards R, Settleman J, McCormick F. Abstract 3182: Cytoskeletal modulation results in increased tumor survival and drug resistance through attenuation of p53 dependent apoptosis. Cancer Res 2017. [DOI: 10.1158/1538-7445.am2017-3182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
43
Mittempergher L, Spangler JB, Snel MH, Delahaye LJ, Rink ID, Tian S, Glas AM, Bernards R. Abstract 5409: Assessment of the MammaPrint 70-gene profile using RNA sequencing technology. Cancer Res 2017. [DOI: 10.1158/1538-7445.am2017-5409] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
44
Dwane L, O'Connor AE, Mulrane L, Dirac AM, Jirstrom K, Crown JP, Bernards R, Gallagher WM, Chonghaile TN, O'Connor DP. Abstract 3040: Functional genomic screening identifies USP11 as a novel regulator of ERα transcription in breast cancer. Cancer Res 2017. [DOI: 10.1158/1538-7445.am2017-3040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
45
Sobral-Leite M, Vijver KVD, Michaut M, Horlings HM, Severson TM, Schouten PC, Linden RVD, Kersten K, Mulligan AM, Weerasooriya N, Sanders J, Cimino-Mathews A, Peters D, Hooijer GK, Hooijberg E, Broeks A, Bernards R, Linn S, Andrulis IL, Vijver MJVD, Wessels LF, Kok M, Visser KED, Schmidt MK. Abstract 575: PD-L1 positive tumor-infiltrating lymphocytes and mutational load in breast cancer. Cancer Res 2017. [DOI: 10.1158/1538-7445.am2017-575] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
46
Delahaye LJMJ, Drukker CA, Dreezen C, Witteveen A, Chan B, Snel M, Beumer IJ, Bernards R, Audeh MW, Van't Veer LJ, Glas AM. A breast cancer gene signature for indolent disease. Breast Cancer Res Treat 2017;164:461-466. [PMID: 28451965 PMCID: PMC5487706 DOI: 10.1007/s10549-017-4262-0] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2017] [Accepted: 04/19/2017] [Indexed: 01/17/2023]
47
Oliveira M, Baird RD, van Rossum AGJ, Beelen K, Garcia-Corbacho J, Mandjes IAM, Vallier AL, van Werkhoven E, Garrigós L, Kumar S, van Tinteren H, Muñoz S, Linossi C, Rosing H, Miquel JM, Schrier M, de Vries Schultink A, Saura C, Gallagher WM, Bernards R, Tabernero J, Cortés J, Caldas C, Linn SC. Abstract OT2-01-11: Phase II of POSEIDON: A phase Ib / randomized phase II trial of tamoxifen plus taselisib or placebo in hormone receptor positive, HER2 negative, metastatic breast cancer patients with prior exposure to endocrine treatment. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-ot2-01-11] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
48
O'Connor DP, Walsh L, Tarrant F, Chin SF, Schouten P, Linn S, Bernards R, Caldas C, Gallagher WM, ni Chonghaile T. Abstract P6-11-06: Bromodomain inhibitors represent a rational therapeutic option for the treatment of invasive lobular carcinoma. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p6-11-06] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
49
Sinha S, Thomas D, Chan S, Gao Y, Brunen D, Torabi D, Reinisch A, Bernards R, Majeti R, Dill DL. Abstract A27: Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer primary tumor data. Clin Cancer Res 2017. [DOI: 10.1158/1557-3265.pmccavuln16-a27] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
50
Beumer IJ, Persoon M, Witteveen A, Dreezen C, Chin SF, Sammut SJ, Snel M, Caldas C, Linn S, van ’t Veer LJ, Bernards R, Glas AM. Prognostic Value of MammaPrint® in Invasive Lobular Breast Cancer. Biomark Insights 2016;11:139-146. [PMID: 27980389 PMCID: PMC5153320 DOI: 10.4137/bmi.s38435] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2016] [Revised: 10/16/2016] [Accepted: 10/22/2016] [Indexed: 12/31/2022]  Open
PrevPage 2 of 9 1234589Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA